Ligo Bio Analysis
What is Ligo Bio?
Ligo Bio develops generative models to design new enzymes, enhancing biocatalysis efficiency in the chemical industry.
Employees
4
Founded
2024
Product Features & Capabilities
- Enzyme design models, deep learning for catalysis, foundational enzyme design, synthesis of high-value chemicals, tailored enzymes for pharmaceuticals, detergents, fragrances, and agricultural chemicals, faster and cost-effective enzyme development.
Who are the founders of Ligo Bio
EH
AG
Arda Goreci
CTO
Business Model
Generative enzyme design for cost-effective biocatalysis; revenue from licensing and partnerships.
Investors
- A.Capital Ventures
- Hawktail
- North South Ventures
- Oxonian Ventures
- Ritual Capital
- Y Combinator
Market Focus
Ligo Bio primarily focuses on the chemical industry, specifically in the area of biocatalysis through the development of generative models that design new enzymes.
Competitors Overview
Ligo Bio operates in the biocatalysis and enzyme design market, where it faces competition from several notable companies. Key competitors include:
- Novozymes A/S: A leader in enzyme production, Novozymes is known for its innovative enzyme technologies and commitment to sustainability. They o
See something that needs updating? Suggest edits to this profile.